SCHEMBL25539374

SCHEMBL25539374

CC1(C)c2ccc(-c3ccc(-c4nc(-c5ccccc5)cc(-c5ccc6c(c5)-c5ccccc5C6(c5ccccc5)c5ccccc5)n4)c4ccccc34)cc2-c2cc3ccccc3cc21

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A1 P04798 1/20 0.33
CYP1B1 Q16678 1/20 0.33
ACACA Q13085 1/20 0.32
MEN1 O00255 4/20 0.32
MAPT P10636 4/20 0.32
KMT2A Q03164 4/20 0.32
ALDH1A1 P00352 3/20 0.32
HPGD P15428 3/20 0.32
KDM4E B2RXH2 3/20 0.32
LMNA P02545 3/20 0.32
GLA P06280 1/20 0.32
PDK2 Q15119 2/20 0.31
CTRC Q99895 1/20 0.31
CHRNA1 P02708 1/20 0.31
CHRNG P07510 1/20 0.31
CHRNB1 P11230 1/20 0.31
CHRNB2 P17787 1/20 0.31
SLC6A2 P23975 1/20 0.31
CHRNB4 P30926 1/20 0.31
SLC6A4 P31645 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25539373 0.99 CYP1A1 (0.32) CYP1A1CYP1B1ACACAMEN1MAPT
SCHEMBL25538840 0.99 CYP1A1 (0.33) CYP1A1CYP1B1ACACAMEN1MAPT
SCHEMBL25538838 0.96 CYP1A1 (0.34) CYP1A1CYP1B1ACACAMEN1MAPT
SCHEMBL25535214 0.96 MEN1 (0.35) CYP1A1CYP1B1ACACAMEN1MAPT
SCHEMBL25534022 0.94 MEN1 (0.35) CYP1A1CYP1B1ACACAMEN1MAPT
SCHEMBL25539357 0.94 CYP1A1 (0.36) CYP1A1CYP1B1ACACAMEN1MAPT
SCHEMBL25538829 0.94 CYP1A1 (0.36) CYP1A1CYP1B1ACACAMEN1MAPT
SCHEMBL25539354 0.94 CYP1A1 (0.36) CYP1A1CYP1B1ACACAMEN1MAPT
SCHEMBL25536923 0.93 MEN1 (0.34) CYP1A1CYP1B1MEN1MAPTKMT2A
SCHEMBL25534918 0.92 TDP1 (0.34) CYP1A1CYP1B1ACACAMEN1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230167072-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-06-01 US disclosed
US-20230167072-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-06-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230167072-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE PIEZO1, LEF1, L1CAM CYP1A1 888/4885CYP1B1 1273/4885ACACA 1790/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.